Treatment of inflammatory bowel disease in the elderly: An update

Drugs and Aging

Volumn 19, Issue 5, 2002, Pages 355-363

  Pardi, Darrell S ^a,b   Loftus Jr , Edward V ^a   Camilleri, Michael ^a  

^a MAYO CLINIC   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; AZATHIOPRINE; BALSALAZIDE; CORTICOSTEROID; CYCLOSPORIN; HYDROCORTISONE; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; METRONIDAZOLE; OLSALAZINE; PREDNISONE; SALAZOSULFAPYRIDINE;

AGED; ANUS DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DIFFERENTIAL DIAGNOSIS; DIVERTICULITIS; DRUG INDICATION; ENTERITIS; FISTULA; HUMAN; INFLAMMATORY DISEASE; ISCHEMIC COLITIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; REMISSION; REVIEW; SIDE EFFECT; ULCERATIVE COLITIS;

EID: 0036076867     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-200219050-00004     Document Type: Review

References (35)

1. Inflammatory bowel disease in the elderly
2. Epidemiology of inflammatory bowel disease: An update
3. Colitis in the elderly
4. Inflammatory bowel disease in the elderly patient
5. Inflammatory bowel disease in the elderly
6. Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: Incidence, prevalence, and survival
7. Crohn's disease in Olmsted County, Minnesota, 1940-1993: Incidence, prevalence, and survival
8. Infectious colitis endoscopically simulating inflammatory bowel disease: A prospective evaluation
9. Crohn's disease in the elderly: A comparison with young adults
10. Crohn's disease in the elderly
11. Drug-responsive chronic segmental colitis associated with diverticula: A clinical syndrome in the elderly
12. Crohn's disease in the elderly. A statistical comparison with younger patients matched for sex and duration of disease
13. Abdominal surgery in the older Crohn's population
14. Crohn's disease: Influence of age at diagnosis on site and clinical type of disease
15. Ulcerative colitis practice guidelines in adults
16. Balsalazide
17. The complications of systemic corticosteroid treatment in the elderly
18. Corticosteroid-associated complications in elderly Crohn's disease patients
19. Prevention and treatment of osteoporosis in patients with inflammatory bowel disease
20. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis
21. A review of immune modifier therapy for inflammatory bowel disease: Azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate
22. Azathioprine and allopurinol: The price of an avoidable drug interaction
23. Management of Crohn's disease in adults
24. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor-α for Crohn's disease
25. Methotrexate treatment for Crohn's disease
26. Methotrexate effects in patients with rheumatoid arthritis with cardiovascular comorbidity
27. Use of methotrexate in older patients. A risk-benefit assessment
28. Clinical outcome following treatment of refractory inflammatory and fistulizing Crohn's disease with intravenous cyclosporin
29. Infliximab for the treatment of fistulas in patients with Crohn's disease
30. Treatment of fistulizing Crohn's disease
31. Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease
32. Mesalamine in the maintenance treatment of Crohn's disease: Meta-analysis adjusted for confounding variables
33. Post-operative prophylaxis with 6MP, 5-ASA or placebo in Crohn's disease: A 2 year multicenter trial
34. Transdermal nicotine for mildly to moderately active ulcerative colitis
35. Budesonide. A review of its pharmacological properties and therapeutic efficacy in inflammatory bowel disease